PROPERTIES OF ANTIVIRAL AGENTS: Second of Two Parts
- 8 September 1984
- journal article
- review article
- Published by Elsevier in The Lancet
- Vol. 324 (8402) , 562-564
- https://doi.org/10.1016/s0140-6736(84)90774-8
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Human Interferon as a Therapeutic Agent — Current StatusNew England Journal of Medicine, 1983
- Ribavirin aerosol treatment of influenza B virus infectionJAMA, 1983
- Toxic effects of interferon administered intrathecally.BMJ, 1983
- Intrathecal Use of Interferon in EncephalitisNew England Journal of Medicine, 1981
- Interferon therapy: Pharmacokinetic and pharmacological aspectsArchiv für die gesamte Virusforschung, 1981
- INTERFERON IN TREATMENT OF SUBACUTE SCLEROSING PANENCEPHALITISThe Lancet, 1981
- Rimantadine hydrochloride blocks the second step of influenza virus uncoatingArchiv für die gesamte Virusforschung, 1980
- Controlled Clinical Trial of Prophylactic Human-Leukocyte Interferon in Renal TransplantationNew England Journal of Medicine, 1979
- Administration of Human Leukocyte Interferon in Herpes Zoster. I. Safety, Circulating Antiviral Activity, and Host Responses to InfectionThe Journal of Infectious Diseases, 1974
- Rubella Virus: Inhibition in vitro by Amantadine HydrochlorideScience, 1964